← Eichor
Study identifier: NCT07669753 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Advancing Cancer Control Engaged Research Through Transformative Solutions (ACCERT) Social Determinants of Health (SDoH) Navigation Program

Condition: Cancer · Cancer , Healthy  ·  Sponsor: Northwestern University

PhaseNA
Planned participants750
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

The purpose of this study is to evaluate patient navigation programs designed to reduce barriers to cancer screening and improve healthcare experiences for adults living in Chicago. Participants will be asked to complete two surveys: the first survey shortly after the participants join the study and a second survey after 1 year. Participants will be joining one of three patient navigation programs, assigned at random. The investigators expect the participants to be in this patient navigation program for 12 months, followed by a 1-month window to complete the final survey.

This description comes directly from the study's public registry record.

Talk to the study team

Melissa Simon  ·  (312) 503-8780  ·  m-simon2@northwestern.edu

Ivy Leung  ·  312-503-0751  ·  ivy.leung@northwestern.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Northwestern UniversityChicago, Illinois, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07669753